Global Eosinophilic Esophagitis Drug Market Growth 2020-2025
According to this study, over the next five years the Eosinophilic Esophagitis Drug market will register a 5.7%% CAGR in terms of revenue, the global market size will reach $ 141.8 million by 2025, from $ 113.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Eosinophilic Esophagitis Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Eosinophilic Esophagitis Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Eosinophilic Esophagitis Drug, covering the supply chain analysis, impact assessment to the Eosinophilic Esophagitis Drug market size growth rate in several scenarios, and the measures to be undertaken by Eosinophilic Esophagitis Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Budesonide
Fluticasone
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Drugstore
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Celgene
GSK
Adare Pharmaceuticals
DBV Technologies
Bayer
Takeda
Dr. Falk Pharma
Calypso
Quorum Innovations
Regeneron
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Eosinophilic Esophagitis Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Eosinophilic Esophagitis Drug market by identifying its various subsegments.
Focuses on the key global Eosinophilic Esophagitis Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Eosinophilic Esophagitis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Eosinophilic Esophagitis Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eosinophilic Esophagitis Drug Consumption 2015-2025
2.1.2 Eosinophilic Esophagitis Drug Consumption CAGR by Region
2.2 Eosinophilic Esophagitis Drug Segment by Type
2.2.1 Budesonide
2.2.2 Fluticasone
2.2.3 Others
2.3 Eosinophilic Esophagitis Drug Consumption by Type
2.3.1 Global Eosinophilic Esophagitis Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Eosinophilic Esophagitis Drug Sale Price by Type (2015-2020)
2.4 Eosinophilic Esophagitis Drug Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstore
2.5 Eosinophilic Esophagitis Drug Consumption by Application
2.5.1 Global Eosinophilic Esophagitis Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Eosinophilic Esophagitis Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Eosinophilic Esophagitis Drug Sale Price by Type (2015-2020)
3 Global Eosinophilic Esophagitis Drug by Company
3.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Company
3.1.1 Global Eosinophilic Esophagitis Drug Sales by Company (2018-2020)
3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Company (2018-2020)
3.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Company
3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Company (2018-2020)
3.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Company (2018-2020)
3.3 Global Eosinophilic Esophagitis Drug Sale Price by Company
3.4 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Eosinophilic Esophagitis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Eosinophilic Esophagitis Drug by Regions
4.1 Eosinophilic Esophagitis Drug by Regions
4.2 Americas Eosinophilic Esophagitis Drug Consumption Growth
4.3 APAC Eosinophilic Esophagitis Drug Consumption Growth
4.4 Europe Eosinophilic Esophagitis Drug Consumption Growth
4.5 Middle East & Africa Eosinophilic Esophagitis Drug Consumption Growth
5 Americas
5.1 Americas Eosinophilic Esophagitis Drug Consumption by Countries
5.1.1 Americas Eosinophilic Esophagitis Drug Consumption by Countries (2015-2020)
5.1.2 Americas Eosinophilic Esophagitis Drug Value by Countries (2015-2020)
5.2 Americas Eosinophilic Esophagitis Drug Consumption by Type
5.3 Americas Eosinophilic Esophagitis Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Eosinophilic Esophagitis Drug Consumption by Regions
6.1.1 APAC Eosinophilic Esophagitis Drug Consumption by Regions (2015-2020)
6.1.2 APAC Eosinophilic Esophagitis Drug Value by Regions (2015-2020)
6.2 APAC Eosinophilic Esophagitis Drug Consumption by Type
6.3 APAC Eosinophilic Esophagitis Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Eosinophilic Esophagitis Drug by Countries
7.1.1 Europe Eosinophilic Esophagitis Drug Consumption by Countries (2015-2020)
7.1.2 Europe Eosinophilic Esophagitis Drug Value by Countries (2015-2020)
7.2 Europe Eosinophilic Esophagitis Drug Consumption by Type
7.3 Europe Eosinophilic Esophagitis Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Eosinophilic Esophagitis Drug by Countries
8.1.1 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Eosinophilic Esophagitis Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Type
8.3 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Eosinophilic Esophagitis Drug Distributors
10.3 Eosinophilic Esophagitis Drug Customer
11 Global Eosinophilic Esophagitis Drug Market Forecast
11.1 Global Eosinophilic Esophagitis Drug Consumption Forecast (2021-2025)
11.2 Global Eosinophilic Esophagitis Drug Forecast by Regions
11.2.1 Global Eosinophilic Esophagitis Drug Forecast by Regions (2021-2025)
11.2.2 Global Eosinophilic Esophagitis Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Eosinophilic Esophagitis Drug Forecast by Type
11.8 Global Eosinophilic Esophagitis Drug Forecast by Application
12 Key Players Analysis
12.1 AstraZeneca
12.1.1 Company Information
12.1.2 Eosinophilic Esophagitis Drug Product Offered
12.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Celgene
12.2.1 Company Information
12.2.2 Eosinophilic Esophagitis Drug Product Offered
12.2.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Celgene Latest Developments
12.3 GSK
12.3.1 Company Information
12.3.2 Eosinophilic Esophagitis Drug Product Offered
12.3.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 GSK Latest Developments
12.4 Adare Pharmaceuticals
12.4.1 Company Information
12.4.2 Eosinophilic Esophagitis Drug Product Offered
12.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Adare Pharmaceuticals Latest Developments
12.5 DBV Technologies
12.5.1 Company Information
12.5.2 Eosinophilic Esophagitis Drug Product Offered
12.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 DBV Technologies Latest Developments
12.6 Bayer
12.6.1 Company Information
12.6.2 Eosinophilic Esophagitis Drug Product Offered
12.6.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer Latest Developments
12.7 Takeda
12.7.1 Company Information
12.7.2 Eosinophilic Esophagitis Drug Product Offered
12.7.3 Takeda Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Takeda Latest Developments
12.8 Dr. Falk Pharma
12.8.1 Company Information
12.8.2 Eosinophilic Esophagitis Drug Product Offered
12.8.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Dr. Falk Pharma Latest Developments
12.9 Calypso
12.9.1 Company Information
12.9.2 Eosinophilic Esophagitis Drug Product Offered
12.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Calypso Latest Developments
12.10 Quorum Innovations
12.10.1 Company Information
12.10.2 Eosinophilic Esophagitis Drug Product Offered
12.10.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Quorum Innovations Latest Developments
12.11 Regeneron
12.11.1 Company Information
12.11.2 Eosinophilic Esophagitis Drug Product Offered
12.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Regeneron Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Eosinophilic Esophagitis Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Budesonide
Table 5. Major Players of Fluticasone
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Eosinophilic Esophagitis Drug Consumption Market Share by Type (2015-2020)
Table 9. Global Eosinophilic Esophagitis Drug Revenue by Type (2015-2020) ($ million)
Table 10. Global Eosinophilic Esophagitis Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Eosinophilic Esophagitis Drug Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Eosinophilic Esophagitis Drug Consumption Market Share by Application (2015-2020)
Table 14. Global Eosinophilic Esophagitis Drug Value by Application (2015-2020)
Table 15. Global Eosinophilic Esophagitis Drug Value Market Share by Application (2015-2020)
Table 16. Global Eosinophilic Esophagitis Drug Sale Price by Application (2015-2020)
Table 17. Global Eosinophilic Esophagitis Drug Sales by Company (2017-2019) (K Units)
Table 18. Global Eosinophilic Esophagitis Drug Sales Market Share by Company (2017-2019)
Table 19. Global Eosinophilic Esophagitis Drug Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company (2017-2019)
Table 21. Global Eosinophilic Esophagitis Drug Sale Price by Company (2017-2019)
Table 22. Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Eosinophilic Esophagitis Drug Products Offered
Table 24. Eosinophilic Esophagitis Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Eosinophilic Esophagitis Drug Consumption by Regions 2015-2020 (K Units)
Table 26. Global Eosinophilic Esophagitis Drug Consumption Market Share by Regions 2015-2020
Table 27. Global Eosinophilic Esophagitis Drug Value by Regions 2015-2020 ($ Millions)
Table 28. Global Eosinophilic Esophagitis Drug Value Market Share by Regions 2015-2020
Table 29. Americas Eosinophilic Esophagitis Drug Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Eosinophilic Esophagitis Drug Consumption Market Share by Countries (2015-2020)
Table 31. Americas Eosinophilic Esophagitis Drug Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Eosinophilic Esophagitis Drug Value Market Share by Countries (2015-2020)
Table 33. Americas Eosinophilic Esophagitis Drug Consumption by Type (2015-2020) (K Units)
Table 34. Americas Eosinophilic Esophagitis Drug Consumption Market Share by Type (2015-2020)
Table 35. Americas Eosinophilic Esophagitis Drug Consumption by Application (2015-2020) (K Units)
Table 36. Americas Eosinophilic Esophagitis Drug Consumption Market Share by Application (2015-2020)
Table 37. APAC Eosinophilic Esophagitis Drug Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Eosinophilic Esophagitis Drug Consumption Market Share by Countries (2015-2020)
Table 39. APAC Eosinophilic Esophagitis Drug Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Eosinophilic Esophagitis Drug Value Market Share by Regions (2015-2020)
Table 41. APAC Eosinophilic Esophagitis Drug Consumption by Type (2015-2020) (K Units)
Table 42. APAC Eosinophilic Esophagitis Drug Consumption Market Share by Type (2015-2020)
Table 43. APAC Eosinophilic Esophagitis Drug Consumption by Application (2015-2020) (K Units)
Table 44. APAC Eosinophilic Esophagitis Drug Consumption Market Share by Application (2015-2020)
Table 45. Europe Eosinophilic Esophagitis Drug Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Eosinophilic Esophagitis Drug Consumption Market Share by Countries (2015-2020)
Table 47. Europe Eosinophilic Esophagitis Drug Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Eosinophilic Esophagitis Drug Value Market Share by Countries (2015-2020)
Table 49. Europe Eosinophilic Esophagitis Drug Consumption by Type (2015-2020) (K Units)
Table 50. Europe Eosinophilic Esophagitis Drug Consumption Market Share by Type (2015-2020)
Table 51. Europe Eosinophilic Esophagitis Drug Consumption by Application (2015-2020) (K Units)
Table 52. Europe Eosinophilic Esophagitis Drug Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Eosinophilic Esophagitis Drug Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Eosinophilic Esophagitis Drug Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Application (2015-2020)
Table 61. Eosinophilic Esophagitis Drug Distributors List
Table 62. Eosinophilic Esophagitis Drug Customer List
Table 63. Global Eosinophilic Esophagitis Drug Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Eosinophilic Esophagitis Drug Consumption Market Forecast by Regions
Table 65. Global Eosinophilic Esophagitis Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Eosinophilic Esophagitis Drug Value Market Share Forecast by Regions
Table 67. Global Eosinophilic Esophagitis Drug Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Eosinophilic Esophagitis Drug Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Eosinophilic Esophagitis Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Eosinophilic Esophagitis Drug Value Market Share Forecast by Type (2021-2025)
Table 71. Global Eosinophilic Esophagitis Drug Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Eosinophilic Esophagitis Drug Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Eosinophilic Esophagitis Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Eosinophilic Esophagitis Drug Value Market Share Forecast by Application (2021-2025)
Table 75. AstraZeneca Product Offered
Table 76. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. AstraZeneca Main Business
Table 78. AstraZeneca Latest Developments
Table 79. AstraZeneca Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Celgene Product Offered
Table 81. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Celgene Main Business
Table 83. Celgene Latest Developments
Table 84. Celgene Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Product Offered
Table 86. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. GSK Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Adare Pharmaceuticals Product Offered
Table 91. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Adare Pharmaceuticals Main Business
Table 93. Adare Pharmaceuticals Latest Developments
Table 94. Adare Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. DBV Technologies Product Offered
Table 96. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. DBV Technologies Main Business
Table 98. DBV Technologies Latest Developments
Table 99. DBV Technologies Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer Product Offered
Table 101. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Bayer Main Business
Table 103. Bayer Latest Developments
Table 104. Bayer Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Takeda Product Offered
Table 106. Takeda Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Takeda Main Business
Table 108. Takeda Latest Developments
Table 109. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Dr. Falk Pharma Product Offered
Table 111. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Dr. Falk Pharma Main Business
Table 113. Dr. Falk Pharma Latest Developments
Table 114. Dr. Falk Pharma Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Calypso Product Offered
Table 116. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Calypso Main Business
Table 118. Calypso Latest Developments
Table 119. Calypso Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Quorum Innovations Product Offered
Table 121. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Quorum Innovations Main Business
Table 123. Quorum Innovations Latest Developments
Table 124. Quorum Innovations Basic Information, Company Total Revenue (in $ million), Eosinophilic Esophagitis Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Regeneron Product Offered
Table 126. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. Regeneron Main Business
Table 128. Regeneron Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Regeneron Latest Developments
List of Figures
Figure 1. Picture of Eosinophilic Esophagitis Drug
Figure 2. Eosinophilic Esophagitis Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Eosinophilic Esophagitis Drug Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Eosinophilic Esophagitis Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Budesonide
Figure 7. Product Picture of Fluticasone
Figure 8. Product Picture of Others
Figure 9. Global Eosinophilic Esophagitis Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Eosinophilic Esophagitis Drug Value Market Share by Type (2015-2020)
Figure 11. Eosinophilic Esophagitis Drug Consumed in Hospitals
Figure 12. Global Eosinophilic Esophagitis Drug Market: Hospitals (2015-2020) (K Units)
Figure 13. Global Eosinophilic Esophagitis Drug Market: Hospitals (2015-2020) ($ Millions)
Figure 14. Eosinophilic Esophagitis Drug Consumed in Clinics
Figure 15. Global Eosinophilic Esophagitis Drug Market: Clinics (2015-2020) (K Units)
Figure 16. Global Eosinophilic Esophagitis Drug Market: Clinics (2015-2020) ($ Millions)
Figure 17. Eosinophilic Esophagitis Drug Consumed in Drugstore
Figure 18. Global Eosinophilic Esophagitis Drug Market: Drugstore (2015-2020) (K Units)
Figure 19. Global Eosinophilic Esophagitis Drug Market: Drugstore (2015-2020) ($ Millions)
Figure 20. Global Eosinophilic Esophagitis Drug Consumption Market Share by Application (2015-2020)
Figure 21. Global Eosinophilic Esophagitis Drug Value Market Share by Application (2015-2020)
Figure 22. Global Eosinophilic Esophagitis Drug Sales Market Share by Company in 2017
Figure 23. Global Eosinophilic Esophagitis Drug Sales Market Share by Company in 2019
Figure 24. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company in 2017
Figure 25. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company in 2019
Figure 26. Global Eosinophilic Esophagitis Drug Sale Price by Company in 2019
Figure 27. Global Eosinophilic Esophagitis Drug Consumption Market Share by Regions 2015-2020
Figure 28. Global Eosinophilic Esophagitis Drug Value Market Share by Regions 2015-2020
Figure 29. Americas Eosinophilic Esophagitis Drug Consumption 2015-2020 (K Units)
Figure 30. Americas Eosinophilic Esophagitis Drug Value 2015-2020 ($ Millions)
Figure 31. APAC Eosinophilic Esophagitis Drug Consumption 2015-2020 (K Units)
Figure 32. APAC Eosinophilic Esophagitis Drug Value 2015-2020 ($ Millions)
Figure 33. Europe Eosinophilic Esophagitis Drug Consumption 2015-2020 (K Units)
Figure 34. Europe Eosinophilic Esophagitis Drug Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Eosinophilic Esophagitis Drug Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Eosinophilic Esophagitis Drug Value 2015-2020 ($ Millions)
Figure 37. Americas Eosinophilic Esophagitis Drug Consumption Market Share by Countries in 2019
Figure 38. Americas Eosinophilic Esophagitis Drug Value Market Share by Countries in 2019
Figure 39. Americas Eosinophilic Esophagitis Drug Consumption Market Share by Type in 2019
Figure 40. Americas Eosinophilic Esophagitis Drug Consumption Market Share by Application in 2019
Figure 41. United States Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 42. United States Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Eosinophilic Esophagitis Drug Consumption Market Share by Countries in 2019
Figure 48. APAC Eosinophilic Esophagitis Drug Value Market Share by Regions in 2019
Figure 49. APAC Eosinophilic Esophagitis Drug Consumption Market Share by Type in 2019
Figure 50. APAC Eosinophilic Esophagitis Drug Consumption Market Share by Application in 2019
Figure 51. China Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 52. China Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 59. India Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 60. India Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Eosinophilic Esophagitis Drug Consumption Market Share by Countries in 2019
Figure 64. Europe Eosinophilic Esophagitis Drug Value Market Share by Countries in 2019
Figure 65. Europe Eosinophilic Esophagitis Drug Consumption Market Share by Type in 2019
Figure 66. Europe Eosinophilic Esophagitis Drug Consumption Market Share by Application in 2019
Figure 67. Germany Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 69. France Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 70. France Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 71. UK Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 72. UK Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Eosinophilic Esophagitis Drug Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Eosinophilic Esophagitis Drug Consumption Market Share by Application in 2019
Figure 81. Egypt Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 82. Egypt Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 84. South Africa Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 86. Israel Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 88. Turkey Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Eosinophilic Esophagitis Drug Consumption Growth 2015-2020 (K Units)
Figure 90. GCC Countries Eosinophilic Esophagitis Drug Value Growth 2015-2020 ($ Millions)
Figure 91. Global Eosinophilic Esophagitis Drug Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 92. Global Eosinophilic Esophagitis Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 94. Americas Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 95. APAC Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 96. APAC Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 97. Europe Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 98. Europe Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 100. Middle East & Africa Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 101. United States Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 102. United States Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 103. Canada Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 104. Canada Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 105. Mexico Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 106. Mexico Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 107. Brazil Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 108. Brazil Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 109. China Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 110. China Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 111. Japan Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 112. Japan Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 113. Korea Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 114. Korea Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 116. Southeast Asia Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 117. India Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 118. India Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 119. Australia Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 120. Australia Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 121. Germany Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 122. Germany Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 123. France Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 124. France Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 125. UK Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 126. UK Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 127. Italy Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 128. Italy Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 129. Russia Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 130. Russia Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 131. Spain Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 132. Spain Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 133. Egypt Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 134. Egypt Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 135. South Africa Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 136. South Africa Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 137. Israel Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 138. Israel Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 139. Turkey Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 140. Turkey Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Eosinophilic Esophagitis Drug Consumption 2021-2025 (K Units)
Figure 142. GCC Countries Eosinophilic Esophagitis Drug Value 2021-2025 ($ Millions)
Figure 143. AstraZeneca Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 144. Celgene Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 145. GSK Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 146. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 147. DBV Technologies Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 148. Bayer Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 149. Takeda Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 150. Dr. Falk Pharma Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 151. Calypso Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 152. Quorum Innovations Eosinophilic Esophagitis Drug Market Share (2018-2020)
Figure 153. Regeneron Eosinophilic Esophagitis Drug Market Share (2018-2020)
